We confirmed that such reduction is an early and common event of thyroid neoplastic transformation, either in vivo by using a BRAFV600E mouse model of TC and in vitro in RAS oncogene-transformed rat thyroid follicular cells, where we also show that oncogenic activation directly represses the activity of the KLHL14 promoter. This evidence concerns the gene KLHL14 and thyroid gland disorder.